Flow cytometric analyses showed that 76.9% of EPN cells expressed GFAP, a tumor glial marker, while 5.5% showed positive staining for CD133, and an important percentage (99.4%) of these cells also expressed CD90 (Figure 3). The gene discussed is GFAP; the disease is neoplasm.